Filtered By:
Countries: France Health
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 2568 results found since Jan 2013.
Nirmatrelvir/ritonavir (Paxlovid ®): French pharmacovigilance survey 2022
CONCLUSION: Overall, this analysis shows that nirmatrelvir/ritonavir safety profile was conform to current summary of product characteristics (SmPC). The main concern was the risk of DDI. Therefore, SmPC and expert recommendations should be systematically consulted before initiation of this antiviral, which is particularly indicated in polypharmacy patients. A case-by-case multidisciplinary approach including a clinical pharmacologist is required in these complex situations. Blood pressure elevation, confusion, cutaneous reactions and AKIs were the main unexpected ADRs of interest to follow, but need to be confirmed with a...
Source: Therapie - April 3, 2023 Category: Psychiatry & Psychology Authors: Kevin Bihan Lor ène Lipszyc Florian Lemaitre Anne Dautriche Sophie F édrizzi Marina Atzenhoffer Aur élie Vitores Annabelle Page B énédicte Lebrun-Vignes Source Type: research
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
CONCLUSION: The study highlighted the role of the spontaneous reporting system in the detection, assessment, and quantification of myocarditis related to m-RNA vaccines. It suggested from September 2021 that mRNA-1273 was reasonably related to a higher risk of myocarditis than BNT162b2 in people under 30, particularly after the second injection.PMID:37012151 | PMC:PMC9990878 | DOI:10.1016/j.therap.2023.03.003
Source: Therapie - April 3, 2023 Category: Psychiatry & Psychology Authors: Francesco Salvo Antoine Pariente Marie Blanche Valnet-Rabier Milou-Daniel Drici Clement Cholle Clement Mathieu Allison Singier Haleh Bagheri Martine Tebacher Joelle Micallef Sophie Gautier French Network of Regional Pharmacovigilance Centers Source Type: research
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
CONCLUSION: This non-exhaustive review illustrates the experience of RFCRPV in identifying and monitoring pharmacovigilance signals related to mRNA vaccines in France during the COVID-19 pandemics, and the crucial role of pharmacological and clinical expertise in this area. It also highlights the predominant contribution of spontaneous reporting in the generation of pharmacovigilance signals, particularly for serious and rare adverse events not detected before marketing.PMID:37012149 | PMC:PMC10007713 | DOI:10.1016/j.therap.2023.03.005
Source: Therapie - April 3, 2023 Category: Psychiatry & Psychology Authors: Marie-Blanche Valnet-Rabier Martine Tebacher Sophie Gautier Joelle Micallef Francesco Salvo Antoine Pariente Haleh Bagheri Source Type: research
Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program
CONCLUSION: The constraints likely affected the time-to-colonoscopy as well as the colonoscopy detection rate without impacting the SAE's occurrence, highlighting the need for a respectable reference time-to-colonoscopy in CRCSP.PMID:36998423 | PMC:PMC10044857 | DOI:10.3748/wjg.v29.i9.1492
Source: World Journal of Gastroenterology - March 31, 2023 Category: Gastroenterology Authors: Ako ï Koïvogui Catherine Vincelet Ga ëlle Abihsera Hamou Ait-Hadad H élène Delattre Tu Le Trung Agn ès Bernoux Rachel Carroll J érôme Nicolet Source Type: research
